Hypertension Clinical Trial
— CCMOfficial title:
Nursing Management in Patients With Hypertension
NCT number | NCT04411355 |
Other study ID # | 494582 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | December 15, 2012 |
Est. completion date | April 15, 2016 |
Verified date | May 2020 |
Source | Ege University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background: This study was conducted to examine the effect of planned educational
intervention based on The Chronic Care Model (CCM) on the management of hypertension in
patients with hypertension. The Chronic Care Model is a framework for organizing and
improving chronic illness care, based on a proactive, planned approach that incorporates
patient self-care, provider, and system level interventions. Several instruments have been
developed to evaluate the effects of CCM implementation on care and treatment outcomes.The
Patient Assessment of Chronic Illness Care (PACIC) questionnaire is used in instrument to
evalate the delivery of care for patients.
Methods: The study was performed a prospective and conducted with a controlled
semi-experimental pattern in matched groups. 30 patients including 15 intervention and 15
control group patients matched in terms of socio-demographic features were monitored for six
months. The intervention group was trained and monitored by a professional team in line with
the components of the model. Life quality scale, hypertension information questions and
chronic care assessment scale were applied to both groups at the beginning and in the sixth
month of the study.
Trial registration: The study was conducted in accordance with the World Medical Association
Declaration of Helsinki of 1964, and approved by local authorities and local Bioethics
Committees(BC) in participating university hospital. (Ethics committee approval
No:B.30.2.EGE.0.20.05.00/OY/649/268 Decision No: 13-3.3/12) Permissions for the use of scale
of PACIC and model of CCM were taken via e-mail.
Key Words: nursing; chronic care model; hypertension
Status | Completed |
Enrollment | 30 |
Est. completion date | April 15, 2016 |
Est. primary completion date | February 15, 2014 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility |
Inclusion Criteria:* Being in the 18-65 age group - Being literate - No sensory losses such as vision and hearing - Willingness to participate in the study - Being open to communication and cooperation - Internet access and availability - To have a phone that can be reached - Having a diagnosis of hypertension at least 6 months ago - According to JNC-6,1997 classification, high blood pressure level is normal, stage 1,2 and 3, risk group A and B, no additional organ damage - Not having metabolic disturbances or diseases that prevent to from participating in the study. Exclusion Criteria:Not being a volunteer - Not complying with inclusion criteria |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Ege University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The Patient Assessment of Chronic Illness Care (PACIC) | The tool was developed in 2005 by Glasgow and is allowing the evaluation of health care services offered to chronic patients by patients,easy to apply,20 items short tool.PACIC,created in line with the basic 6 elements of the CCM,consists of 5 subdimensions;*Patient Activation (items 1-3),*Delivery System Design/Decision Support (items 4-6),*Goal Setting (items 7-11),*Problem-solving/Contextual Counseling (items 12-15),*Follow-up/Coordination (items 16-20).The total score of the scale is calculated by the average score of all 20 items.The average score of each sub-dimension are measured by a 5-point Likert-type grading. The increase in scale scores indicates that individuals with chronic diseases have high satisfaction with the care patients receive and that chronic disease management is sufficient.The validity and reliability of theTurkish version of the scale was done by Incirkus and Nahcivan(2010). | 6 months | |
Primary | WHOQOL-BREF(TR) quality of life assessment | The WHOQOL-BREF(TR)scale developed from WHOQOL-100 to evaluate the quality of life.The cultural adaptation of the scale inTurkey performed by Eser(1999).The Turkish versionof the scale,27th question,national environmental area has been added as"Area V"; Area I:Physical area:To be able to carry out daily tasks,dependence on drugs, treatment, vitality,fatigue,physical activity,pain,discomfortsleep,rest,ability to work. Area II:Mental area:Body image and appearance,negative emotions,memory, distraction. Area III:Social relations area:Relations with other people,social support,sexual life. Area IV:Environmental area:Financial resources,physical security,accessibility to health services,home environment,opportunity to use rest,leisure time,physical environment, transportation. Area V:National environmental area:cultural area The total score is range from a min.of 27 to a max.of 135. |
6 months | |
Primary | Hypertensive nephropathy | The reduced glomerular filtration rate (eGFR). GFR rate is calculated using a mathematical formula that compares a person's size, age, sex, and race to serum creatinine levels. A normal GFR 60 mL/min/1.73 m² .the lower the GFR number, the worse the kidney function. | 6 months | |
Secondary | HbA1c levels as the clinical indicator | The HbA1c test evaluates the average amount of glucose in the blood in the last 3 months. Traditionally, in our country, HbA1c is expressed as a percentage. The normal HbA1c value is between 4 and 6 mg/dl. |
3. and 6. month | |
Secondary | Blood glucose levels as the clinical indicator | peripheral blood will be checked and at least 8 hours fasting blood sugar level 70-100 mg/dl | 6. month | |
Secondary | The indicator of perfusion to vital organs | The mean arterial pressure (MAP) MAP = 1/3 (systolic blood pressure - diastolic blood pressure) + diastolic blood pressure | 6. month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |